Magnetar Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-834,390
| Closed | -$49M | – | 521 |
|
|
2023
Q4 | $49M | Buy |
+834,390
| New | +$49M | 1.24% | 24 |
|
|
2023
Q2 | – | Sell |
-21,875
| Closed | -$813K | – | 685 |
|
|
2023
Q1 | $813K | Buy |
+21,875
| New | +$813K | 0.02% | 411 |
|
|
2022
Q3 | – | Sell |
-7,807
| Closed | -$524 | – | 1655 |
|
|
2022
Q2 | $524 | Sell |
7,807
-6,098
| -44% | -$409 | 0.01% | 1129 |
|
|
2022
Q1 | $1.14M | Buy |
+13,905
| New | +$1.14M | 0.01% | 774 |
|
|
2021
Q3 | – | Sell |
-1,783
| Closed | -$288 | – | 1566 |
|
|
2021
Q2 | $288 | Buy |
+1,783
| New | +$288 | ﹤0.01% | 1036 |
|
|
2021
Q1 | – | Sell |
-3,719
| Closed | -$817K | – | 1218 |
|
|
2020
Q4 | $817K | Buy |
+3,719
| New | +$817K | 0.01% | 502 |
|
|
2020
Q1 | – | Sell |
-1,554
| Closed | -$200K | – | 674 |
|
|
2019
Q4 | $200K | Buy |
+1,554
| New | +$200K | ﹤0.01% | 496 |
|